 STONY BROOK, N.Y.--BUSINESS WIRE--- APDN--Applied DNA Sciences, Inc. NASDAQ: APDN Applied DNA or the Company, a leader in Polymerase Chain Reaction PCR-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day. An archived webcast will be available 